ES2625829T3 - Conjugados y sus usos en la obtención de imágenes moleculares - Google Patents
Conjugados y sus usos en la obtención de imágenes moleculares Download PDFInfo
- Publication number
- ES2625829T3 ES2625829T3 ES11788554.1T ES11788554T ES2625829T3 ES 2625829 T3 ES2625829 T3 ES 2625829T3 ES 11788554 T ES11788554 T ES 11788554T ES 2625829 T3 ES2625829 T3 ES 2625829T3
- Authority
- ES
- Spain
- Prior art keywords
- bifunctional
- bifunctional compound
- group
- molecule
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1027—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
- A61K51/1033—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants against receptors for cytokines, lymphokines or interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201019118A GB201019118D0 (en) | 2010-11-11 | 2010-11-11 | Conjugates and their uses in molecular imaging |
| GB201019118 | 2010-11-11 | ||
| PCT/GB2011/001599 WO2012063028A1 (en) | 2010-11-11 | 2011-11-11 | Conjugates and their uses in molecular imaging |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2625829T3 true ES2625829T3 (es) | 2017-07-20 |
Family
ID=43431334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES11788554.1T Active ES2625829T3 (es) | 2010-11-11 | 2011-11-11 | Conjugados y sus usos en la obtención de imágenes moleculares |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9138495B2 (enExample) |
| EP (1) | EP2637705B1 (enExample) |
| JP (1) | JP5986095B2 (enExample) |
| AU (1) | AU2011327931B2 (enExample) |
| ES (1) | ES2625829T3 (enExample) |
| GB (1) | GB201019118D0 (enExample) |
| WO (1) | WO2012063028A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7098442B2 (en) | 2003-03-05 | 2006-08-29 | Raytheon Company | Thin micropolarizing filter, and a method for making it |
| WO2012123755A1 (en) | 2011-03-17 | 2012-09-20 | The University Of Birmingham | Re-directed immunotherapy |
| US11077210B2 (en) | 2013-10-31 | 2021-08-03 | Beth Israel Deaconess Medical Center | Near-infrared fluorescent contrast bioimaging agents and methods of use thereof |
| US11001562B2 (en) | 2013-10-31 | 2021-05-11 | Beth Israel Deaconess Medical Center | Near-infrared fluorescent nerve contrast agents and methods of use thereof |
| GB201417067D0 (en) | 2014-09-26 | 2014-11-12 | South African Nuclear Energy | Radiopharmaceutical conjugate |
| GB201504064D0 (en) * | 2015-03-10 | 2015-04-22 | Accretion Biotechnology Ltd | Method and kits for preparing radionuclide complexes |
| JP7253762B2 (ja) * | 2017-12-27 | 2023-04-07 | 慈濟大學 | タンパク質を表面に発現させた小胞によるオートファジー細胞およびアポトーシス細胞への薬剤送達 |
| US12440585B2 (en) | 2023-09-12 | 2025-10-14 | Curadel Surgical Innovations, Inc. | Zwitterionic metal chelators |
| CN120590625A (zh) * | 2024-11-06 | 2025-09-05 | 江苏申命医疗科技有限公司 | 一种放射性核素标记的聚合物、其制备方法及应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| ATE199392T1 (de) | 1992-12-04 | 2001-03-15 | Medical Res Council | Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung |
| AU2865995A (en) | 1995-06-14 | 1997-01-15 | Regents Of The University Of California, The | 3-hydroxy-2(1h)-pyridinone chelating agents |
| US8926945B2 (en) * | 2005-10-07 | 2015-01-06 | Guerbet | Compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium |
| US8158804B2 (en) | 2007-01-11 | 2012-04-17 | Ge Healthcare As | Chelating agents |
| US8475768B2 (en) | 2007-08-13 | 2013-07-02 | Ge Healthcare As | Paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (MRI) |
| US9209965B2 (en) | 2014-01-14 | 2015-12-08 | Microsemi Semiconductor Ulc | Network interface with clock recovery module on line card |
-
2010
- 2010-11-11 GB GB201019118A patent/GB201019118D0/en not_active Ceased
-
2011
- 2011-11-11 EP EP11788554.1A patent/EP2637705B1/en active Active
- 2011-11-11 US US13/884,660 patent/US9138495B2/en active Active
- 2011-11-11 JP JP2013538264A patent/JP5986095B2/ja active Active
- 2011-11-11 ES ES11788554.1T patent/ES2625829T3/es active Active
- 2011-11-11 WO PCT/GB2011/001599 patent/WO2012063028A1/en not_active Ceased
- 2011-11-11 AU AU2011327931A patent/AU2011327931B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| GB201019118D0 (en) | 2010-12-29 |
| EP2637705A1 (en) | 2013-09-18 |
| AU2011327931A2 (en) | 2013-07-11 |
| AU2011327931A1 (en) | 2013-07-04 |
| US9138495B2 (en) | 2015-09-22 |
| JP5986095B2 (ja) | 2016-09-06 |
| WO2012063028A1 (en) | 2012-05-18 |
| JP2014501714A (ja) | 2014-01-23 |
| EP2637705B1 (en) | 2017-03-29 |
| US20140056810A1 (en) | 2014-02-27 |
| AU2011327931B2 (en) | 2017-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2011327931B2 (en) | Conjugates and their uses in molecular imaging | |
| AU619738B2 (en) | Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy | |
| Dearling et al. | Imaging cancer using PET—the effect of the bifunctional chelator on the biodistribution of a 64Cu-labeled antibody | |
| Reissig et al. | Modulating the pharmacokinetic profile of Actinium-225-labeled macropa-derived radioconjugates by dual targeting of PSMA and albumin | |
| CN103608043B (zh) | α‑放射性络合物 | |
| ES2864091T3 (es) | Inmunomoduladores de producción de imágenes de tomografía por emisión de positrones (PET) | |
| CA2822693C (en) | Radiolabled her2 binding peptides | |
| Ekblad et al. | Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake | |
| CN102438656B (zh) | 预靶向试剂盒、方法和其中使用的试剂 | |
| Van Gog et al. | Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics | |
| CN110357967B (zh) | 新型成像组合物及其用途 | |
| Cheng et al. | 64Cu-labeled affibody molecules for imaging of HER2 expressing tumors | |
| Floresta et al. | Recent progress in the imaging of c‐Met aberrant cancers with positron emission tomography | |
| US20150359913A1 (en) | Tetrazines/trans-cyclooctenes in solid phase synthesis of labeled peptides | |
| CA2873143A1 (en) | Radio-pharmaceutical complexes | |
| CN102316903A (zh) | Pdgf-rbeta结合剂 | |
| Boss et al. | Comparative studies of three pairs of α-and γ-conjugated folic acid derivatives labeled with fluorine-18 | |
| US20160199500A1 (en) | Compositions comprising vitamin b12 and intrinsic factor and methods of use thereof | |
| ES2794581T3 (es) | Procedimientos y kits para preparar complejos de radionúclidos | |
| CA2998420A1 (en) | Compositions for therapeutics, targeted pet imaging and methods of their use | |
| Joaqui-Joaqui et al. | Catechol-based functionalizable ligands for gallium-68 positron emission tomography imaging | |
| CN116554146A (zh) | 一种FAP-α特异性放射性药物及其应用 | |
| Hoppmann et al. | Radiolabeled affibody-albumin bioconjugates for HER2 positive cancer targeting | |
| Choi et al. | Synthesis and evaluation of 68 Ga‐HBED‐CC‐EDBE‐folate for positron‐emission tomography imaging of overexpressed folate receptors on CT26 tumor cells | |
| Feng et al. | Development of a novel 99mTc-labeled folate derivative containing phenyl isonitrile to target folate receptor with reduced renal uptake |